Healthcare’s Problem With Logic
Medicine has always relied on intuition, that prescient gut instinct. But intuition is outcomes focused. Instead, we need logic, which...
Monkeypox, COVID, and Racism
With viruses dominating headlines, it is no surprise that the latest Monkeypox outbreak garners headlines. But the way we cover...
Origins of the Drug Resistant Pandemic
For most, prescribing antibiotics is a simple decision made reflexively. However, that decision, seemingly logical in the moment, becomes dangerous...
A Game of Healthcare Law
In game theory, outcomes depend on the nature of the game and the payoffs. Healthcare is a game of incomplete...
The Great COVID Vaccine Bet
The CDC must decide whether to proceed with a new generation of vaccines that promise longer immunity. But many unknowns...
What Really Happened In Wuhan?
A call for an independent investigation into the origins of COVID-19 renews interest in the virus's mutation patterns. It also...
Summer of Healthcare
This summer promises to be tumultuous with many polarizing health issues coming to a head. The pending convergence provides an...
Medicine & Law Cannot Get Along
Medicine and law have strained their relationship, butting heads on a host of issues of late. The problem lies in...
How to Enforce Health Laws
In recent weeks, a slew of newly enacted health laws or revised interpretations emerged. Despite the changes, the means to...
Are COVID Cases Really Rising?
We have seen an increase in COVID cases over the past weeks. The ensuing emotions expressed due to this rise...
Startup Innovation Meets DOJ Regulations
Marketing in healthcare has always been murky. For healthcare startups, it is downright dangerous, as it is where many Department...
Medicare Advantage Versus Traditional Medicare
A report found most Medicare Advantage plans offer little value over traditional Medicare. We should now question the need for...
Videos
Glucagon-Like Peptide–Based Therapies and Longevity: Clinical Implications from Emerging Evidence
Glucagon-like peptide–based therapies are increasingly used for weight management and glycemic control, but their potential impact on long-term survival remains uncertain. The clinical question addressed in this report is whether treatment with glucagon-like peptide receptor agonists is associated with reductions in all-cause mortality and age-related morbidity beyond their established metabolic effects. This question matters because these agents are now prescribed across broad patient populations, including individuals without diabetes, and long-term exposure may influence cardiovascular, oncologic, and neurodegenerative outcomes. Understanding whether...
Read more